Business Standard

Friday, December 20, 2024 | 11:35 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Fortis Hospital

Fortis opens 80-bed tertiary hospital in Bengaluru, invests about Rs 7 cr

Fortis Hospital aims for an Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) growth of about 20 per cent

Fortis opens 80-bed tertiary hospital in Bengaluru, invests about Rs 7 cr
Updated On : 19 Apr 2024 | 9:23 PM IST

'Average length of stay' at hospitals are becoming shorter by the day

'Every hospital now tracks length of stay closely. We cannot keep on increasing the critical care beds,' says Dr Bishnu Panigrahi, group head, medical strategy and operations, Fortis Healthcare

'Average length of stay' at hospitals are becoming shorter by the day
Updated On : 25 Mar 2024 | 11:06 PM IST

Fortis launches institute for specialised treatment of blood cancer

A well-known private healthcare group, Fortis on Friday inaugurated a state-of-the-art facility for the specialised treatment of blood cancers and disorders, which it said "represented a critical step" in addressing the urgent need for comprehensive holistic care. The Fortis Institute of Blood Disorders also integrates paediatric and geriatric care, advanced transplant procedures, and hematopathology expertise, all under one roof, Fortis Healthcare said in a release. The Institute also launched CAR-T cell therapy to its extensive network of Bone Marrow Transplant centres in Mohali, Delhi, Gurgaon, Noida, Mumbai and Bangalore, the statement said. This initiative is supported by a commercial collaboration with ImmunoACT, an IIT-Bombay spin-off and pioneer in India's first fully indigenous and commercially approved gene-modified cell therapy. The NexCAR19, India's first market-authorised CAR-T cell therapy, offers a new ray of hope for treating B-cell lymphomas and B-acute lymphoblast

Fortis launches institute for specialised treatment of blood cancer
Updated On : 05 Jan 2024 | 7:22 PM IST

M&As to drive hospital expansion in uncharted territory, say experts

Inorganic expansion gives instant market share in a new geography, greenfield works better in markets where a chain already has a presence, say industry players and analysts

M&As to drive hospital expansion in uncharted territory, say experts
Updated On : 18 Nov 2022 | 11:10 PM IST

Religare Finvest, Fortis' officials pay Rs 4.3 cr to settle case with Sebi

n investigation was initiated by Sebi in the matter of Fortis Healthcare Ltd (FHL) after an article published in February 2018 said its promoters have taken at least Rs 500 crore out of FHL

Religare Finvest, Fortis' officials pay Rs 4.3 cr to settle case with Sebi
Updated On : 31 Jan 2022 | 5:25 PM IST

Fortis-OP Jindal hospital to expand bed capacity two-fold in Chhattisgarh

State CM lays foundation of Phase-2 project of the hospital. Centre will construct facility on 50,000 sq ft at an estimated cost of Rs 25 cr

Fortis-OP Jindal hospital to expand bed capacity two-fold in Chhattisgarh
Updated On : 29 Jun 2020 | 5:48 PM IST

Separate infra needed for Covid-19 patients with other ailments: Fortis CEO

The hospital has chosen not to cut salaries of frontline health workers even as its looks to implement cost saving measures

Separate infra needed for Covid-19 patients with other ailments: Fortis CEO
Updated On : 05 May 2020 | 9:49 PM IST

Fortis board directors urge shareholders to take 'informed decision'

Fortis has called for an extraordinary general meeting (EGM) on May 22 to vote on the resolution of removal of four Fortis board directors

Fortis board directors urge shareholders to take 'informed decision'
Updated On : 09 May 2018 | 11:30 PM IST

Fortis stock up 17.6% amid merger talk after Singh bros resign from board

Meanwhile, shares of Fortis soared 17.6 per cent on Friday amid reports that the Manipal Hospital, backed by TPG, was in advanced talks to merge itself with the company

Fortis stock up 17.6% amid merger talk after Singh bros resign from board
Updated On : 09 Feb 2018 | 10:20 PM IST

Fortis in talks for fresh capital of Rs 50 bn as part of Singhs' stake sale

Fortis is also exploring other structures for a capital infusion, which could result in dilution for existing shareholders, Singh said

Fortis in talks for fresh capital of Rs 50 bn as part of Singhs' stake sale
Updated On : 05 Jan 2018 | 4:02 PM IST

Dengue death: Gurgaon Fortis' blood bank, pharmacy licences suspended

The hospital has been barred from selling drugs and medicines on its premises

Dengue death: Gurgaon Fortis' blood bank, pharmacy licences suspended
Updated On : 30 Dec 2017 | 9:30 PM IST

Fortis allegedly 'bribed' father of deceased girl; hospital denies charge

The girl was referred to the Fortis Memorial Research Institute, Gurgaon, as a case of dengue shock syndrome in a critical condition

Fortis allegedly 'bribed' father of deceased girl; hospital denies charge
Updated On : 08 Dec 2017 | 9:46 AM IST